OXSQ has unusually thin sell-side coverage, which prevents a reliable average analyst price target. The most widely cited figure is a single $1.75 target from Lucid Capital Markets, set with a "Hold" rating when coverage was initiated in October 2025. Because one target does not constitute a meaningful consensus, this article uses a fallback objective instead. The $1.20 level is grounded in a valuation argument: OXSQ's latest reported NAV per share of $1.21, disclosed with third-quarter 2026 results. BDCs are conventionally evaluated against book value, and a recovery toward NAV is a common, publicly discussed price objective for shares trading at a discount. The rounded $1.20 figure sits about 30% above the current price and is derived from public valuation benchmarks rather than an analyst consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of early November 2026, OXSQ traded near $0.92, down about 51% over the trailing 52 weeks, with a 52-week range of roughly $0.78 to $2.05. Reaching $1.20 would require a gain of approximately 30% — a substantial move for a high-yield BDC. The path would likely require a stabilization in NAV, an improvement in net investment income (NII), and renewed investor confidence in the sustainability of the distribution. In its most recent quarter, NII fell to about $4.9 million, or $0.04 per share, from $5.1 million, or $0.05 per share, in the prior quarter, while total investment income held relatively steady near $9.9 million.
The clearest support is valuation: at roughly 0.75x book value, shares trade well below the latest NAV of $1.21 per share. If credit conditions remain benign and portfolio losses narrow, a partial re-rating toward book value is possible. The stock also offers a forward dividend yield near 45%, which can attract income-focused buyers when the payout is viewed as defensible. Stable total investment income and continued loan and CLO investment activity provide a base of recurring earnings, and the company's low beta (around 0.37) suggests less day-to-day volatility than the broader market.
The risks are material. The board's decision to cut the monthly distribution to $0.015 per share for the months ending January, February, and March 2027 signals pressure on distributable income. NAV per share has declined from about $1.69 a year ago to $1.21, partly reflecting realized and unrealized losses — about $3.3 million in the latest quarter alone. The company has also been issuing shares through an ATM program (roughly 14.1 million shares for about $19.4 million in net proceeds in one quarter), which dilutes existing holders and can weigh on NAV per share. Trailing EPS (earnings per share) is negative, and a sustained economic slowdown could further pressure the leveraged-loan and CLO exposure that anchors the portfolio.
The 52-week low near $0.78 is the most important support level to watch; a decisive break below it would signal further downside. On the upside, the $1.00 mark is a natural psychological resistance level, and a move above it would represent an early step toward the $1.20 objective. The former NAV levels around $1.21 to $1.29 are no longer support but can act as reference points for a recovery. The stock's long-term trend has been downward over the past year, so any sustained advance would require a change in that structure rather than a single bounce.
The lone analyst target carries an implied research horizon of about 12 months, but with such thin coverage that should be treated cautiously. Investors should monitor quarterly NAV updates and NII trends, any further distribution declarations, credit spreads and default rates across leveraged loans and CLOs, interest-rate decisions from the Federal Reserve, and the pace of ATM share issuance. Revisions to the single published analyst target, or the addition of new coverage, would also be meaningful signals for the OXSQ price forecast. From what I see, these factors are worth tracking closely.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a high-yield, high-volatility name like OXSQ, these signals can help traders spot shifting trends and manage positions more efficiently. In my view, the tool adds useful perspective when reviewing holdings like this one.
Whether OXSQ can reach $1.20 depends less on headline momentum than on whether the company can halt the erosion of its book value and distribution. The $1.20 objective, anchored to the latest NAV of $1.21, requires a substantial ~30% advance and is not backed by a meaningful analyst consensus — only a single $1.75 Hold target from Lucid Capital Markets exists. A steep discount to NAV and a high yield provide a plausible case for mean reversion, but declining NII, negative earnings, the recent distribution cut, and ongoing share dilution are significant obstacles. Investors should watch quarterly NAV, distribution announcements, and credit-market conditions closely. No outcome is guaranteed, and this article is not a recommendation to buy or sell.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
OXSQ saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 26, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In 34 of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 67%.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OXSQ as a result. In 52 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
OXSQ moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OXSQ crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OXSQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where OXSQ advanced for three days, in 119 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
OXSQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 72 of 200 cases where OXSQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 36%.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.736) is normal, around the industry mean (2.436). P/E Ratio (-2.144) is within average values for comparable stocks, (-3.642). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.152) settles around the average of (0.272) among similar stocks. OXSQ's P/S Ratio (74.139) is slightly higher than the industry average of (15.694).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. OXSQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OXSQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a private equity fund
Industry InvestmentManagers